- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04131868
Sleep and Girls' Emotions Study (SAGE)
November 2, 2019 updated by: Melynda Casement, University of Oregon
The Contribution of Stressful Life Events and Insufficient Sleep to Reward-Related Brain Function and Depression in Adolescent Girls
This study evaluates whether increasing sleep duration can increase neural and behavioral response to rewards and decrease depressive symptoms in 18- to 22-year-old women with insufficient sleep and depressive symptoms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Eugene, Oregon, United States, 97403
- University of Oregon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 22 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Insufficient sleep (total sleep time < 8 hours per night, with sleepiness scores ≥ 6 on the Epworth Sleepiness Scale OR ≥ 16 on the PROMIS Sleep Related Impairment Scale)
- Symptoms of depression (≥ 15 on the Center for Epidemiological Studies for Depression Scale)
Exclusion Criteria:
- Current insomnia, hypersomnia, sleep disordered breathing, sleep movement disorder, or circadian rhythm disorder
- History of head injury with loss of consciousness within the past two years
- History of head injury with loss of consciousness two or more years ago and meet criteria for post concussion syndrome
- Neurological disorder
- Use of psychiatric medications
- Current psychotic symptoms
- Active suicidal ideation
- Conditions that are contraindicated for MRI (e.g., ferromagnetic material in the body)
- Meet criteria for current substance use disorder with greater than mild severity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Extended sleep opportunity
|
Extended sleep opportunity by 90 min per night with consistent sleep timing for 1 week
|
|
ACTIVE_COMPARATOR: Typical sleep opportunity
|
Typical sleep opportunity with consistent sleep timing for 1 week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms
Time Frame: 1 week
|
Center for Epidemiological Studies Depression Scale score.
The CESD-R is a 20-item measure of the frequency of depressive symptoms, with each item rated on a scale from 0 (not at all or less than one day) to 5 (nearly every day).
Total scores range from 0 to 100, with higher scores indicating greater number and frequency of depressive symptoms.
|
1 week
|
|
Reward-related brain function
Time Frame: 1 week
|
BOLD fMRI response during Reward Guessing Task
|
1 week
|
|
Sleep duration
Time Frame: 1 week
|
Mean actigraphy-measured sleep duration
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive affect
Time Frame: 1 week
|
International Positive and Negative Affect Scale Short Form - Positive Affect score.
The I-PANAS-SF is a 10-item scale that asks participants to rate the extent to which 5 positive and 5 negative adjectives describe them on a scale of 1 (never) to 5 (always).
Scores for each positive adjective are summed to produce a Positive Affect (PA) score ranging from 5 to 25, with higher scores indicating more positive affect.
|
1 week
|
|
Negative affect
Time Frame: 1 week
|
International Positive and Negative Affect Scale Short Form - Negative Affect score.
The I-PANAS-SF is a 10-item scale that asks participants to rate the extent to which 5 positive and 5 negative adjectives describe them on a scale of 1 (never) to 5 (always).
Scores for each negative adjective are summed to produce a Negative Affect (PA) score ranging from 5 to 25, with higher scores indicating more negative affect.
|
1 week
|
|
Reward effort
Time Frame: 1 week
|
Effort Expenditure for Rewards Task score
|
1 week
|
|
Reward-related functional connectivity
Time Frame: 1 week
|
BOLD fMRI psychophysiological striatal-medial prefrontal cortex interaction
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 19, 2018
Primary Completion (ACTUAL)
April 25, 2019
Study Completion (ACTUAL)
July 7, 2019
Study Registration Dates
First Submitted
October 16, 2019
First Submitted That Met QC Criteria
October 16, 2019
First Posted (ACTUAL)
October 18, 2019
Study Record Updates
Last Update Posted (ACTUAL)
November 5, 2019
Last Update Submitted That Met QC Criteria
November 2, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K01MH103511 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Extended sleep opportunity
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingSleep | Obesity, Childhood | Binge Eating | Self-regulationUnited States
-
University of PittsburghCompletedMild Cognitive Impairment
-
University of Colorado, DenverCompletedDiabetes Mellitus, Type 2 | SleepUnited States
-
McGill University Health Centre/Research Institute...The Arthritis Society, CanadaRecruitingRheumatic Diseases | Vasculitis | Inflammatory Arthritis | Muskuloskeletal Diseases | Systemic Autoimmune Diseases | Systemic Lupus Erthematosus (SLE)Canada
-
The Affiliated Hospital Of Guizhou Medical UniversityNot yet recruiting
-
Asociación Colombiana de HepatologíaRecruitingHepatitis C Virus InfectionColombia
-
University of OklahomaOklahoma Center for the Advancement of Science and TechnologyCompleted
-
Liverpool University Hospitals NHS Foundation TrustNot yet recruitingMedical Education | Quality ImprovementUnited Kingdom
-
University of AarhusCompletedBreast Cancer Female | Decision Making | Mammography Screening | Information Seeking BehaviorDenmark